Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/28/14
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 02/21/18
End: 09/30/21
Due: 09/30/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R | NCT02045368 | IGF Oncology, LLC | user2@example.com | None | 2014-01-28 | 2016-09-30 | 2017-09-30 | - | - | 2025-07-14 |
| IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome | NCT03175978 | IGF Oncology, LLC | user2@example.com | None | 2018-02-21 | 2021-09-30 | 2022-09-30 | - | - | 2025-07-14 |